Use of SLIT, nephrin, ephrin or semaphorin for treatment of cartilage diseases

Details for Australian Patent Application No. 2008297889 (hide)

Owner Scil Technology GmbH

Inventors Bosserhoff, Anja; Schubert, Thomas; Hustert, Elisabeth

Agent Davies Collison Cave

Pub. Number AU-A-2008297889

PCT Pub. Number WO2009/033715

Priority 08006810.9 03.04.08 EP; 07018131.8 14.09.07 EP

Filing date 12 September 2008

Wipo publication date 19 March 2009

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61P 19/02 (2006.01) Drugs for skeletal disorders

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/033715 Priority application(s): WO2009/033715

2 February 2012 Assignment before Grant

  Scil Technology GmbH The application has been assigned to Formycon GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008297891-Use of gonadorelin as a therapeutic agent

2008297888-Use of a peptide as a therapeutic agent